Abstract
Background and aims
H-type hypertension is essential hypertension combined with high homocysteine, and both synergistically increase the risk of cardiovascular and cerebrovascular events. The aim of this study was to investigate the risk factors of H-type hypertension in Tibetan plateau population and correlation with MTHFR C677T gene.
Methods and results
A multi-stage cluster random sampling method was used to select the research subjects in Tibet Autonomous Region from June 2020 to November 2021. Among Tibetans, the incidence of H-type hypertension accounted for 84.31% of hypertensive patients. The logistic regression analysis demonstrated that age, uric acid (UA), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C) were risk factors for the prevalence of H-type hypertension, the OR (95% CI) was 1.083(1.073–1.094), 1.002(1.001–1.004), 1.240(1.050–1.464) and 2.274(1.432–3.611), respectively. MTHFR C677T TT genotype patients with H-type hypertension OR (95% CI) was 1.629(1.004–2.643). Based on this, a nomogram model was established, and the reliability of the model was proved by area under ROC curve, Brier score and average absolute error. The model’s results indicate that for every five years of age, the score increases by 6 points; for a 2mmol/L increase in TG, the score increases by 5.5 points; for a 1mmol/L increase in LDL-C, the score increases by 10 points; and individuals with the TT genotype receive 8 points. The higher the score, the greater the risk of disease.
Conclusion
The MTHFR C677T TT genotype is a risk locus for Tibetan patients with H-type hypertension, with age, TG, and LDL-C were identified as risk factors for the disease.
Introduction
In the Chinese population, the prevalence of H-type hypertension was found to be 26.9% in the total population, including 81.8% of men and 62.8% of women, and 73.1% in patients with hypertension [1]. Hyperhomocysteinemia may be a potential independent risk factor for cardiovascular disease, dementia, and other related disorders [2], and a degree of synergy between hypertension and hyperhomocysteinemia can lead to an increased burden on the cardiovascular system. This suggests that the coexistence of hypertension and hyperhomocysteinemia may exacerbate the overall risk and impact of these conditions on individuals’ health. Studies have estimated that the incidence of adverse cardiovascular events in patients with H-type hypertension is approximately five times higher than in patients with essential hypertension alone and approximately 25–30 times higher than in the healthy population [3] 0.5,10-methylenetetrahydrofolate reductase (MTHFR) plays an important role as a key enzyme in folate metabolism and plasma Hcy remethylation in the body, and the C677T (rs1801133) locus gene of MTHFR is the most common one that can lead to reduced or diminished activity of the MTHFR enzyme and subsequent elevation of blood Hcy levels [4, 1). The higher the total score, the greater the risk of develo** H-type hypertension.
By calculating the C-index of this model (equivalent to the AUC under the ROC curve) as 0.808 (95% CI: 0.788–0.828), it suggests that the model exhibits a relatively strong discriminatory ability (Fig. 2).The calibration curve shows that the calibration curve is basically close to the predicted curve and the ideal curve, with the Brier score = 0.132 and the Mean absolute error = 0.013,indicates a satisfactory level of accuracy in the model’s predictions (Fig. 3).Furthermore, the Hosmer-Lemeshow (H-L) fit curve was χ2 = 11.848, p = 0.158 > 0.05, the difference was not statistically significant, indicating that the model had a strong explanatory power and a good degree of fit.
Discussion
This study showed that the prevalence of H-type hypertension in Tibetan areas among the Tibetan population has reached a notable prevalence of 21.14%, surpassing the previous estimate of 15.1% among Tibetans residing in high-altitude regions [17]. Patients with H-type hypertension accounted for 84.31% of the total hypertensive population, higher than the baseline data of H-type hypertension in 79.68% of the hypertensive population in China from the Essential Stroke Prevention Study [18]. These results may be related to the local population’s exposure to low-pressure, low-oxygen environments, high salt and high-fat diets, and low intake of fresh fruits and vegetables.The H-type hypertension group exhibits a higher average age, with elevated levels of Hcy, TC, TG, LDL-C, UA and CREA compared to the other three groups. This may be due to a decrease in digestive and absorptive capacity with age, as well as impaired hepatic and renal metabolic function, resulting in decreased Hcy clearance. Furthermore, a high-sodium diet may impede the absorption of folate and B-complex vitamins, resulting in an abnormal elevation of plasma Hcy levels, thereby promoting the occurrence of H-type hypertension [25, 26]. The study suggests that TG and LDL-C are independent variables influencing disease progression [27]. Meta-analysis results indicate that in the overall genetic model of the human population, individuals carrying the TT genotype have an increased risk of develo** H-type hypertension [28]. Most studies rely on single logistic regression analysis, which has limitations in interpreting the results. Therefore, combining the construction of a risk prediction model tailored to the local population is of significant practical importance in preventing and controlling the development of H-type hypertension.Based on the results of multifactor logistic regression analysis, this study has developed a nomogram prediction model for H-type hypertension, incorporating seven factors. The model showed that the score increased by 6 points for every 5-year increase in age; the score increased by 9 points for every 200 umol/L increase in UA; the score increased by 5.5 points for every 2-mmol/L increase in TG; the score increased by 10 points for every 1-mmol/L increase in LDLC; and individuals with the TT genotype received a score of 8 points. The higher the total score, the greater the risk of develo** type h hypertension. Abnormal increases in the above indicators lead to varying degrees of risk for the development of H-type hypertension; therefore, it is recommended that the above indicators be included in the monitoring and management of H-type hypertension in the daily management of H-type hypertension.The model’s accuracy and discriminative ability were assessed using the H-L goodness-of-fit curve, AUC, and C-index index. The results indicate that this model possesses a high degree of discrimination and accuracy, making it a valuable tool for healthcare professionals from various fields to preliminarily assess individual disease risk and provide targeted prevention and treatment measures. Studies have demonstrated the efficacy of regular aerobic exercise in stabilizing blood pressure in individuals diagnosed with H-type hypertension [29]. This exercise program not only enhances cardiorespiratory endurance, but contributes to the improvement and management of the patient’s pathological state. Aerobic exercise may be considered as a treatment and management approach for the H-hypertensive population.
The participants in this study were Tibetan people in Tibet who have been living in a high-altitude environment at an average altitude of 4200 m. Further in-depth studies are needed to determine whether the group’s ability to adapt to high altitude, low pressure and low oxygen leads to a different genetic basis and whether the unique Tibetan dietary pattern of high salt and high fat, and low intake of fresh fruits and vegetables due to the survival environment causes differences in the prevalence of H-type hypertension.
Conclusion
The mutation occurring at the MTHFR C677T TT locus is a potential contributing factor to the development of H-type hypertension in the Tibetan population residing in Tibet. Additionally, age, UA, TG, LDL-C and the TT genotype are considered as risk factors for the onset of H-type hypertension in this population. Therefore, it is advocated that hypertensive patients should, in addition to routine blood pressure measurements, regularly monitor their homocysteine (Hcy) levels to prevent the synergistic effects between the two, and implement targeted preventive and control measures. These measures include strengthening health education in agricultural and pastoral regions, improving dietary patterns, promoting scientifically validated aerobic exercise, and incorporating rational interventions such as adequate folate intake.All of these efforts aim to improve the occurrence of adverse cardiovascular and cerebrovascular events.
Limitations
Our study has limitations due to its cross-sectional design, which precludes establishing causal relationships between risk factors and the occurrence of H-type hypertension. In terms of model validation, we only conducted internal validation and lack external validation to assess the model’s generalizability. Additionally, there is currently limited research on the genotypes of H-type hypertension patients in the Tibetan region. Therefore, it is necessary to conduct prospective multicenter cohort studies with larger sample sizes, encompassing various altitudes and geographical regions, to explore the relationship between genetic factors and H-type hypertension in the Tibetan population.
Data availability
The datasets used during the current study are available from the corresponding author on reasonable request.
Abbreviations
- Hcy, homocysteinemia:
-
MTHFR,5,10-methylenetetrahydrofolate reductase
- SBP:
-
Systolic blood pressure
- DBP:
-
Diastolic blood pressure
- ANOVA:
-
One-way analysis of variance
- C-index:
-
Harrell’s C statistical consistency index
- FPG:
-
Fasting plasma glucose;
- TC:
-
Total cholesterol
- HDL-C:
-
High-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol
- UREA:
-
Urea nitrogen;
- CREA:
-
Creatinine; UA, Uric acid
- OR:
-
Odds Ratio;
References
Liang Z, Fan FF, Zhang Y, Qin XH, Li JP, Huo Y. [Rate and characteristics of H-type hypertension in Chinese hypertensive population and comparison with American population]. Bei**g Da Xue Xue Bao. 2022;54:1028–37. https://doi.org/10.19723/j.issn.1671-167X.2022.05.033.
Moretti R, Caruso P. The controversial role of Homocysteine in Neurology: from labs to clinical practice. Int J Mol Sci. 2019;20:231. https://doi.org/10.3390/ijms20010231.
Clarke R, Bennett DA, Parish S, Verhoef P, Dötsch-Klerk M, Lathrop M, et al. Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control studies, avoiding publication Bias. PLoS Med. 2012;9:e1001177. https://doi.org/10.1371/journal.pmed.1001177.
Liu S, Liu M, Li Q, Liu X, Wang Y, Mambiya M, et al. Association of single nucleotide polymorphisms of MTHFR, TCN2, RNF213 with susceptibility to hypertension and blood pressure. Biosci Rep. 2019;39:BSR20191454. https://doi.org/10.1042/BSR20191454.
Zhang C, Li J, Zhou J, Zheng Q, Dong R, **ng E, et al. Effect of MTHFRC677 T gene polymorphism on early morning blood pressure in Elderly Female patients with H-Type hypertension. Contrast Media Mol Imaging. 2022;2022:2530388. https://doi.org/10.1155/2022/2530388.
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–3. https://doi.org/10.1038/ng0595-111.
Holmes MV, Newcombe P, Hubacek JA, Sofat R, Ricketts SL, Cooper J, et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet. 2011;378:584–94. https://doi.org/10.1016/S0140-6736(11)60872-6.
He Q, Wei Y, Zhu H, Liang Q, Chen P, Li S, et al. The combined effect of MTHFR C677T and A1298C polymorphisms on the risk of digestive system cancer among a hypertensive population. Discov Oncol. 2024;15:97. https://doi.org/10.1007/s12672-024-00960-y.
Yang B, Fan S, Zhi X, **a R, Wang Y, Zheng Q, et al. Geographical and ethnic distribution of MTHFR gene polymorphisms and their associations with diseases among Chinese population. Clin Genet. 2017;92:243–58. https://doi.org/10.1111/cge.12929.
Zhang C, **n Q-P, **e Y-B, Guo X-Y, **ng E-H, Dou Z-J, et al. Relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and neutrophil gelatinase-associated lipocalin in early renal injury in H-type hypertension. BMC Cardiovasc Disord. 2024;24:55. https://doi.org/10.1186/s12872-024-03704-6.
Raghubeer S, Matsha TE. Methylenetetrahydrofolate (MTHFR), the one-Carbon cycle, and Cardiovascular risks. Nutrients. 2021;13:4562. https://doi.org/10.3390/nu13124562.
Petrone I, Bernardo PS, dos Santos EC, Abdelhay E. MTHFR C677T and A1298C polymorphisms in breast Cancer, Gliomas and gastric Cancer: a review. Genes. 2021;12:587. https://doi.org/10.3390/genes12040587.
Zhang Y-X, Yang L-P, Gai C, Cheng C-C, Guo Z, Sun H-M, et al. Association between variants of MTHFR genes and psychiatric disorders: a meta-analysis. Front Psychiatry. 2022;13:976428. https://doi.org/10.3389/fpsyt.2022.976428.
Jouibari RM, Movafagh A, Molaei A. Association between maternal and fetal MTHFR C677T and MTRR A66G polymorphisms with the risk of NTDs: a systematic review and Meta-analysis study. Iran Red Crescent Med J. 2021;23:e1350. https://doi.org/10.32592/ircmj.2021.23.11.1350.
Yao C-Y, Lu H-Z, Zhang L-W,Song J-X, He H-X, Zhang R-X et al. [The polymorphism of methylenetetrahydrofolate reductase gene C677Tin Han population in Qinhuangdao]. Chin Prev Med. 2020:21;490–494. https://doi.org/10.16506/j.1009-6639.2020.05.003.
2018 Chinese Guidelines for Prevention and Treatment of Hypertension—A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol JGC. 2019;16:182–241. https://doi.org/10.11909/j.issn.1671-5411.2019.03.014.
Guan H-Y. [Investigation on homocysteine level and its related gene polymorphism of hypertension in native Tibetans]master.Tibet University,2021. https://doi.org/10.27735/d.cnki.gx-zdx.2021.000148.
Qin X, Li Y, Sun N, Wang H, Zhang Y, Wang J, et al. Elevated homocysteine concentrations decrease the Antihypertensive Effect of Angiotensin-converting enzyme inhibitors in Hy-pertensive patients. Arterioscler Thromb Vasc Biol. 2017;37:166–72. https://doi.org/10.1161/ATV-BAHA.116.308515.
Shi X-J, Duan K-D,**ao. Y.[Influence factor analysis of hypertension complicated with hype-rhomocysteinemia]. J Huaihai Med. 2023;41:15–8. https://doi.org/10.14126/j.cnki.1008-7044.2023.01.004.
Xu R, Huang F, Wang Y, Liu Q, Lv Y, Zhang Q. Gender- and age-related differences in homocysteine concentration: a cross-sectional study of the general population of China. Sci Rep. 2020;10:17401. https://doi.org/10.1038/s41598-020-74596-7.
Liu Y, Xu C, Wang Y, Yang C, Pu G, Zhang L, et al. Association analysis of MTHFR (rs1801133 and rs1801131) and MTRR (rs1801394) gene polymorphisms towards the develo-pment of hypertension in the Bai population from Yunnan. China Clin Exp Hypertens. 2023;45:2206066. https://doi.org/10.1080/10641963.2023.2206066.
Chen L. [Association between the polymorphism of MTHFR C677T and H type hypertension in the Han population live in Qinghai Province,China] master. Ningxia Medical University; 2016.
Huang LQ, Wu CX, Wei HQ, Xu G. Clinical characteristics of H-type hypertension and its relationship with the MTHFR C677T polymorphism in a Zhuang population from Guangxi, China. J Clin Lab Anal. 2020;34:e23499. https://doi.org/10.1002/jcla.23499.
Li Q, Sun XL, Song B, Lyu CX, Feng XQ. [Association of small dense low-density lipoprotein cholesterol with H-type hypertension and MTHFR gene polymorphism]. Zhonghua Yu Fang Yi Xue Za Zhi. 2022;56:1844–9. https://doi.org/10.3760/cma.j.cn112150-20220719-00736.
Qian X, Cao H, Zhang J, Gu Z, Tang W, Shen L, et al. The prevalence, relative risk factors and MTHFR C677T genotype of H type hypertension of the elderly hypertensives in Shanghai, China: a cross-section study. BMC Cardiovasc Disord. 2021;21:376. https://doi.org/10.1186/s12872-021-02151-x.
Analysis of metabolism-related indicators. and MTHFR gene polymorphism in patients with H-type hypertension - Minerva Medica 2017 April;108(2):103-7 n.d. https://www.minervamed-ica.it/en/journals/minerva-medica/article.php?cod=R10Y2017N02A0103 (accessed November 7, 2023).
Yuan W, Shao Y, Zhao D, Zhang B. Correlation analysis of lipid accumulation index, triglyceride-glucose index and H-type hypertension and coronary artery disease. PeerJ. 2023;11:e16069. https://doi.org/10.7717/peerj.16069.
Liao S, Guo S, Ma R, He J, Yan Y, Zhang X, et al. Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and H-type hypertension: a systematic review and meta‐analysis. Ann Hum Genet. 2022;86:278–89. https://doi.org/10.1111/ahg.12468.
Miao W. Effects of regular aerobic exercise on cardiorespiratory endurance and blood pressure responses to exercise in patients with h-type hypertension. Acta Med Mediterr 2021:2541–6. https://doi.org/10.19193/0393-6384_2021_4_394.
Acknowledgements
We appreciate the insightful suggestions made by the reviewers and academic editors regarding our article, which will help us improve the quality of the manuscript and shape our future research.
Funding
This study was supported by the Special Funds for the Reform and Development of Local Universities Supported by the Central Government [No.00060585, No.00060695/051]; and Ngari prefecture Science and Technology Program [No.ALKJ-BJCZ-2019-02].
Author information
Authors and Affiliations
Contributions
Jiaojiao Yan: Data curation, Software, Formal Analysis, Writing - Original Draft. Yufei Zhang: Investigation, Data Curation, Writing - Original Draft.Yaxi Zhou: Supervision, Validation, Writing - Original Draft. Yang Wan: Visualization, Formal analysis, Writing - Review & Editing. Hai **ong: Conceptualization, Resources, Project administration, Supervision, Writing - Review & Editing.
Corresponding authors
Ethics declarations
Ethics approval
The study followed the ethical guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of Tibet University. All participants gave informed consent to participate in the study. Participants gave their consent by signing or fingerprinting the informed consent form after receiving information about the content of the project. All participants volunteered to participate in this study.
Consent for publication
Not applicable.
Role of the funder/sponsor
The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Yan, J., Zhang, Y., Zhou, Y. et al. Analysis of MTHFR C677T genotype and related factors in H-type hypertension in Tibet, China. BMC Cardiovasc Disord 24, 345 (2024). https://doi.org/10.1186/s12872-024-04015-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12872-024-04015-6